Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis
Massimo Federico(University of Modena and Reggio Emilia), Bertrand Coiffier(Hospices Civils de Lyon), Silvia Montoto(Queen Mary University of London), Armando López‐Guillermo, Martine E.D. Chamuleau(Dutch Cancer Society), Ewa Paszkiewicz‐Kozik(The Maria Sklodowska-Curie National Research Institute of Oncology), Sara Alonso(Hospital Universitario Central de Asturias), María Gomes da Silva(Instituto Português de Oncologia Francisco Gentil), Martina Manni(University of Modena and Reggio Emilia), Guillaume Cartron(Centre National de la Recherche Scientifique), Yngvild Nuvin Blaker(Oslo University Hospital), Clémentine Sarkozy(Hôpital Lyon Sud), Miguel Alcoceba(Instituto de Investigación Biomédica de Salamanca), Franck Morschhauser, Carla Minoia(Istituto Tumori Bari), Sandra Lockmer(Karolinska University Hospital), Eva Kimby(Karolinska University Hospital), Luigi Marcheselli(University of Modena and Reggio Emilia), Igor Aurer(University Hospital Centre Zagreb), Gilles Salles(Université Claude Bernard Lyon 1), Tetiana Skrypets(University of Modena and Reggio Emilia), Harald Holte, Djamila E. Issa(Jeroen Bosch Ziekenhuis), Emanuele Zucca(Ente Ospedaliero Cantonale), Chiara Rusconi(Fondazione IRCCS Istituto Nazionale dei Tumori), María Dolores Caballero Barrigón(Instituto de Investigación Biomédica de Salamanca), Mariëlle J. Wondergem(Amsterdam UMC Location Vrije Universiteit Amsterdam), Vittoria Tarantino(University of Modena and Reggio Emilia)
Cited by 116
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k